Showing results (71-80 of 82) with videos related to
Sort By:
Pageof 9
JAMA Neurology|June 19, 2018
Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti-α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease: A Randomized Clinical TrialJoseph Jankovic, Ira Goodman, Beth Safirstein, et al.Neurology and Therapy|January 11, 2022
Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson's Disease: Real-World Evidence From G7 CountriesAngelo Antonini, Rajesh Pahwa, Per Odin, et al.Movement Disorders Clinical Practice|January 16, 2026
Considerations for Initiation and Maintenance of Foslevodopa/Foscarbidopa for Advanced Parkinson's DiseaseK Ray Chaudhuri, Bruno Bergmans, Eric Freire-Alvarez, et al.Journal of Parkinson'S Disease|December 13, 2021
Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson's Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD TrialM Judith Peterschmitt, Hidemoto Saiki, Taku Hatano, et al.Tremor and Other Hyperkinetic Movements (New York, N.Y.)|January 12, 2026
Underlying Tremor Improvement with Consistent Use of Transcutaneous Afferent Patterned Stimulation in Patients with Essential TremorStuart H Isaacson, Elizabeth Peckham, Winona Tse, et al.The Lancet. Neurology|March 18, 2024
Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trialAlberto J Espay, Fabrizio Stocchi, Rajesh Pahwa, et al.Tremor and Other Hyperkinetic Movements (New York, N.Y.)|September 1, 2020
Prospective Home-use Study on Non-invasive Neuromodulation Therapy for Essential TremorStuart H Isaacson, Elizabeth Peckham, Winona Tse, et al.JAMA|March 20, 2024
Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With SynucleinopathiesChristopher H Gibbons, Todd Levine, Charles Adler, et al.Frontiers in Neurology|September 3, 2021
LIPAD (LRRK2/Luebeck International Parkinson's Disease) Study Protocol: Deep Phenotyping of an International Genetic CohortTatiana Usnich, Eva-Juliane Vollstedt, Nathalie Schell, et al.Annals of Clinical and Translational Neurology|December 26, 2025
Cutaneous Phosphorylated Alpha-Synuclein in Lewy Body DementiaChristopher H Gibbons, Todd Levine, Charles H Adler, et al.Pageof 9